GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The present study aims at verifying the state of the art in what this illness concerns and at organizing a centralized samples analysis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto

Criteria

Inclusion Criteria:

• Patients aged 16-60

• Diagnosed with previously untreated T-ALL and B-ALL

Exclusion Criteria:

• previously treated ALL patients

• L3 B-ALL